Alterola Biotech, Inc.
ABTI · OTC
3/31/2023 | 3/31/2022 | 9/30/2020 | 9/30/2019 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $2 | $0 | $0 |
| G&A Expenses | $2 | $4 | $0 | $0 |
| SG&A Expenses | $2 | $4 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $2 | $6 | $0 | $0 |
| Operating Income | -$2 | -$6 | -$0 | -$0 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $0 | $0 | $0 | -$0 |
| Pre-Tax Income | -$2 | -$6 | -$0 | -$0 |
| Tax Expense | -$0 | $0 | -$0 | $0 |
| Net Income | -$2 | -$6 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EPS | -0.002 | -0.008 | -0.002 | -0.002 |
| % Growth | 77.4% | -460% | 31.8% | – |
| EPS Diluted | -0.002 | -0.008 | -0.002 | -0.002 |
| Weighted Avg Shares Out | 806 | 770 | 118 | 117 |
| Weighted Avg Shares Out Dil | 806 | 770 | 118 | 117 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$2 | -$6 | -$0 | -$0 |
| % Margin | – | – | – | – |